Hunan Copote Science Technology Co.,Ltd. (SHA:600476)
China · Delayed Price · Currency is CNY 11.56
+0.55 (5.00%)
Apr 30, 2026, 3:00 PM CST
SHA:600476 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 531.29 | 527.67 | 635.88 | 582.47 | 582.79 | 458.83 |
Other Revenue | - | - | 3.24 | 3.04 | 2.99 | 4.3 |
| 531.29 | 527.67 | 639.12 | 585.51 | 585.78 | 463.14 | |
Revenue Growth (YoY) | -6.35% | -17.44% | 9.16% | -0.05% | 26.48% | 35.58% |
Cost of Revenue | 491.82 | 487.12 | 547.39 | 474.48 | 521.08 | 387.15 |
Gross Profit | 39.47 | 40.55 | 91.73 | 111.04 | 64.71 | 75.99 |
Selling, General & Admin | 78.73 | 87.05 | 74.2 | 69.51 | 61.92 | 57.89 |
Research & Development | 1.16 | 1.19 | 8.3 | 10.45 | 31.34 | 8.13 |
Other Operating Expenses | 3.52 | 3.13 | 2.5 | 4.06 | 1.99 | 3.04 |
Operating Expenses | 83.32 | 91.37 | 87.8 | 93.21 | 94.88 | 70.57 |
Operating Income | -43.84 | -50.82 | 3.94 | 17.83 | -30.17 | 5.42 |
Interest Expense | - | - | -10.3 | -10.98 | -7.16 | -4.54 |
Interest & Investment Income | 1.98 | 0.1 | 5.95 | 2.53 | 2.87 | 2.5 |
Currency Exchange Gain (Loss) | - | - | -0 | 0 | 0 | -0 |
Other Non Operating Income (Expenses) | -357.86 | -358.01 | 1.39 | -7.15 | -4.57 | -1.48 |
EBT Excluding Unusual Items | -399.72 | -408.73 | 0.98 | 2.23 | -39.03 | 1.9 |
Gain (Loss) on Sale of Investments | - | - | 7.52 | 0.29 | -5.09 | -8.29 |
Gain (Loss) on Sale of Assets | 0.19 | 0.19 | 0.14 | 0.06 | -0 | - |
Asset Writedown | -61.13 | -61.13 | - | - | - | -0.22 |
Other Unusual Items | - | - | 0.19 | 0.36 | 1.73 | 8.88 |
Pretax Income | -460.66 | -469.67 | 8.83 | 2.95 | -42.39 | 2.26 |
Income Tax Expense | 4.33 | 4.33 | -4.37 | -2.34 | -3.06 | -1.69 |
Earnings From Continuing Operations | -464.99 | -474 | 13.19 | 5.29 | -39.33 | 3.95 |
Net Income | -464.99 | -474 | 13.19 | 5.29 | -39.33 | 3.95 |
Net Income to Common | -464.99 | -474 | 13.19 | 5.29 | -39.33 | 3.95 |
Net Income Growth | - | - | 149.47% | - | - | -10.53% |
Shares Outstanding (Basic) | 162 | 161 | 161 | 160 | 161 | 158 |
Shares Outstanding (Diluted) | 162 | 161 | 161 | 160 | 161 | 158 |
Shares Change (YoY) | 0.40% | 0.11% | 0.40% | -0.18% | 1.51% | -3.37% |
EPS (Basic) | -2.87 | -2.94 | 0.08 | 0.03 | -0.24 | 0.03 |
EPS (Diluted) | -2.87 | -2.94 | 0.08 | 0.03 | -0.24 | 0.03 |
EPS Growth | - | - | 148.49% | - | - | -7.41% |
Free Cash Flow | 150.48 | 145.52 | -82.97 | -89.75 | -67.64 | -50.55 |
Free Cash Flow Per Share | 0.93 | 0.90 | -0.52 | -0.56 | -0.42 | -0.32 |
Gross Margin | 7.43% | 7.68% | 14.35% | 18.96% | 11.05% | 16.41% |
Operating Margin | -8.25% | -9.63% | 0.62% | 3.04% | -5.15% | 1.17% |
Profit Margin | -87.52% | -89.83% | 2.06% | 0.90% | -6.71% | 0.85% |
Free Cash Flow Margin | 28.32% | 27.58% | -12.98% | -15.33% | -11.55% | -10.91% |
EBITDA | -21.06 | -28.42 | 24.82 | 36.46 | -13.8 | 11.65 |
EBITDA Margin | -3.96% | -5.39% | 3.88% | 6.23% | -2.36% | 2.52% |
D&A For EBITDA | 22.78 | 22.4 | 20.88 | 18.63 | 16.37 | 6.23 |
EBIT | -43.84 | -50.82 | 3.94 | 17.83 | -30.17 | 5.42 |
EBIT Margin | -8.25% | -9.63% | 0.62% | 3.04% | -5.15% | 1.17% |
Revenue as Reported | 3.62 | - | 639.12 | 585.51 | 585.78 | 463.14 |
Advertising Expenses | - | - | 0.87 | 1.08 | 1.22 | 0.96 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.